Companies › McKesson Corporation · Global Markets & Policy
McKesson Corporation
- NYSE: MCK
U.S.-listed company (NYSE: MCK) that the SEC classifies under industry code 5122, "Wholesale-Drugs, Proprietaries & Druggists' Sundries".
Next earnings report: Nov 4, 2026. McKesson Corporation quarterly results and earnings history →
Insider trades (Form 4)
Last 120 days: open-market sales $13.6M, purchases $0. All McKesson Corporation insider transactions →
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Napoleon B Rutledge Jr. SVP, Controller & CAO | Open-market sale 10b5-1 plan | 111 | $891.45 | $99K | Form 4 ↗ |
| Aug 10, 2026 | Bradley E Lerman Director | Open-market sale | 301 | $892.33 | $269K | Form 4 ↗ |
| Jul 7, 2026 | Brian S. Tyler Chief Executive Officer, Director | Open-market sale 10b5-1 plan | 8,463 | $793.56 | $6.7M | Form 4 ↗ |
| Jun 17, 2026 | Brian S. Tyler Chief Executive Officer, Director | Open-market sale 10b5-1 plan | 8,463 | $775.13 | $6.6M | Form 4 ↗ |
Key financials
| Metric | FY to Mar 2023 | FY to Mar 2024 | FY to Mar 2025 | FY to Mar 2026 |
|---|---|---|---|---|
| Revenue | $276.7B | $309.0B | $359.1B | $403.4B |
| Operating income | $4.4B | $3.9B | $4.4B | $6.2B |
| Net income | $3.6B | $3.0B | $3.3B | $4.8B |
| Diluted EPS | $25.03 | $22.39 | $25.72 | $38.38 |
Fiscal years, from annual reports (10-K / 20-F). Source: SEC EDGAR (XBRL company facts), retrieved 2026-10-14. Verify figures against the original filings.
Recent filings
- 2026-10-06 · 8-K — Regulation FD disclosure
- 2026-08-28 · 8-K — Regulation FD disclosure
- 2026-08-05 · 10-Q
- 2026-08-05 · 8-K — Results of operations
- 2026-07-24 · 8-K — Shareholder vote results
- 2026-07-01 · 8-K — Director or officer change; Regulation FD disclosure
- 2026-06-12 · DEF 14A
- 2026-06-12 · 8-K — Material agreement; New financial obligation
Source: SEC EDGAR, retrieved 2026-10-14. Filing types explained: 8-K, 10-Q, 10-K, 20-F / 6-K.
Not investment advice. This page lists official filings and our reports for reference. SignalStack does not rate securities or recommend buying or selling anything.